Functional genomics: identifying drug targets for parasitic diseases

被引:13
作者
Cowman, AF [1 ]
Crabb, BS [1 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
基金
英国医学研究理事会; 英国惠康基金;
关键词
D O I
10.1016/j.pt.2003.09.006
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The genomic sequences of parasitic diseases are rapidly becoming available and, recently, the full sequence of Plasmodium falciparum has been published. Much has been promised from this genomic revolution including the identification of new drug targets and novel chemotherapeutic treatments for the control of parasitic diseases. The challenge to use this information efficiently will require functional genomics tools such as bioinformatics, microarrays, proteomics and chemical genomics to identify potential drug targets,, and to allow the development of optimized lead compounds. The information generated from,these tools will provide. a crucial link from genomic analysis to drug discovery.
引用
收藏
页码:538 / 543
页数:6
相关论文
共 41 条
[31]   DNA microarrays for malaria [J].
Rathod, PK ;
Ganesan, K ;
Hayward, RE ;
Bozdech, Z ;
DeRisi, JL .
TRENDS IN PARASITOLOGY, 2002, 18 (01) :39-45
[32]   Identification and functional characterization of thioredoxin from Trypanosoma brucei brucei [J].
Reckenfelderbäumer, N ;
Lüdemann, H ;
Schmidt, H ;
Steverding, D ;
Krauth-Siegel, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (11) :7547-7552
[33]   Origin, targeting, and function of the apicomplexan plastid [J].
Roos, DS ;
Crawford, MJ ;
Donald, RGK ;
Kissinger, JC ;
Klimczak, LJ ;
Striepen, B .
CURRENT OPINION IN MICROBIOLOGY, 1999, 2 (04) :426-432
[34]   Cysteine proteases of malaria parasites: Targets for chemotherapy [J].
Rosenthal, PJ ;
Sijwali, PS ;
Singh, A ;
Shenai, BR .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (18) :1659-1672
[35]   From knowing to controlling: A path from Genomics to drugs using small molecule probes [J].
Strausberg, RL ;
Schreiber, SL .
SCIENCE, 2003, 300 (5617) :294-295
[36]   Drug development for neglected diseases: a deficient market and a public-health policy failure [J].
Trouiller, P ;
Olliaro, P ;
Torreele, E ;
Orbinski, J ;
Laing, R ;
Ford, N .
LANCET, 2002, 359 (9324) :2188-2194
[37]   Genomics in target and drug discovery [J].
van Duin, M ;
Woolson, H ;
Mallinson, D ;
Black, D .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 :429-432
[38]   A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum [J].
Waller, RF ;
Ralph, SA ;
Reed, MB ;
Su, V ;
Douglas, JD ;
Minnikin, DE ;
Cowman, AF ;
Besra, GS ;
McFadden, GI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) :297-301
[39]  
Warhurst David C., 2002, Science Progress, V85, P89, DOI 10.3184/003685002783238906
[40]   Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization [J].
Wilson, W ;
DeRisi, J ;
Kristensen, HH ;
Imboden, P ;
Rane, S ;
Brown, PO ;
Schoolnik, GK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12833-12838